Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье, Новартис АгfiledCriticalЛе Лаборатуар Сервье
Priority claimed from PCT/EP2019/081291external-prioritypatent/WO2020099542A1/en
Publication of EA202191302A1publicationCriticalpatent/EA202191302A1/en
Комбинация: (а) мидостаурина или его фармацевтически приемлемой соли, или его комплекса, или его сокристалла, или его сольвата, включая гидрат, и (б) ингибитора Mcl-1; и ее композиции и применения.A combination of: (a) midostaurine, or a pharmaceutically acceptable salt thereof, or a complex thereof, or a co-crystal thereof, or a solvate thereof, including a hydrate, and (b) an Mcl-1 inhibitor; and its composition and application.
EA202191302A2019-10-082019-11-14
COMBINATION OF Mcl-1 INHIBITOR AND MIDOSTAURINE, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS
EA202191302A1
(en)
Compounds derived from cyclopentane perhydrophenanthrene, fxr modulators; pharmaceutical composition comprising said compounds; and its use for the treatment of cholestatic, fibrotic, hypercholesterolemia diseases, among others.